FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia

Author： Boeckler Frank   Russig Holger   Zhang Weining   Löber Stefan   Schetz John   Hübner Harald   Ferger Boris   Gmeiner Peter   Feldon Joram  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.175, Iss.1, 2004-08, pp. : 7-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist

By Bristow L.J.   Kramer M.S.   Kulagowski J.   Patel S.   Ragan C.I.   Seabrook G.R.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 6, 1997-06 ,pp. : 186-188

Elsevier

Access to resources Recommend Favorite

RBI-257: A highly potent dopamine D 4 receptor-selective ligand

By Kula N.S.   Baldessarini R.J.   Kebabian J.W.   Bakthavachalam V.   Xu L.  

European Journal of Pharmacology, Vol. 331, Iss. 2, 1997-07 ,pp. : 333-336

Elsevier

Access to resources Recommend Favorite

F15063, a potential antipsychotic with dopamine D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

By Assié Marie-Bernadette   Bardin Laurent   Auclair Agnès   Consul-Denjean Nathalie   Sautel François   Depoortère Ronan   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 4, 2007-06 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite

Selective adenosine A 2A receptor/dopamine D 2 receptor interactions in animal models of schizophrenia

By Kafka S.H.   Corbett R.  

European Journal of Pharmacology, Vol. 295, Iss. 2, 1996-01 ,pp. : 147-154

Elsevier

Access to resources Recommend Favorite

Enhancement of antipsychotic-like properties of the dopamine D 2 receptor antagonist, raclopride, by the additional treatment with the 5-HT 2 receptor blocking agent, ritanserin, in the rat

By Wadenberg M.-L.   Salmi P.   Jimenez P.   Svensson T.   Ahlenius S.  

European Neuropsychopharmacology, Vol. 6, Iss. 4, 1996-11 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite